Timing of levodopa therapy: evidence from MPTP-treated primates.
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D000818:Animals; D004195:Disease Models, Animal; D007980:Levodopa / Q000008:administration & dosage*; D008252:Macaca fascicularis; D010300:Parkinson Disease / Q000188:drug therapy*; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D011725:Pyridines; D013997:Time Factors
D011725:Pyridines; D007980:Levodopa; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine